Ivan Peyron/ISTH
Sep 15, 2025, 17:40
Ivan Peyron Encourages You to Support Resaerch Targeting Rare Coagulation Diseases and Platelet Pathologies
Ivan Peyron, Research Engineer at INSERM, shared on LinkedIn:
Support research!
Bleeding disorders and clotting problems are responsible for many serious illnesses and strokes.
Our mission in the laboratory:
- Deciphering the mechanisms of coagulation
- Understanding diseases like von Willebrand disease and hemophilia
- Improving diagnosis and treatment for patients
Thanks to our innovative nanobody platform (mini-antibodies) developed since 2014, we create:
- Unique tools for research
- Promising therapeutic candidates
Our current projects target rare coagulation diseases and platelet pathologies, to transform patients’ lives.
- By making a donation, you are directly contributing to:
- Better Stroke Prevention
- Improving the management of cardiovascular and inflammatory diseases
- Bringing hope to thousands of patients around the world
Support our research and help us make a difference!”
To support the research, follow the link.
Stay updated on the latest news in the field of clotting disorders with Hemostasis Today.
-
Jun 10, 2026, 04:20Ravindra Prasad Thokala: When T Cells Heal and Harm in the Same Transplant Unit
-
Jun 10, 2026, 04:15Jukka Partanen: How Blood Donation Selection Shapes the Human Genome Landscape
-
Jun 10, 2026, 04:02Heghine Khachatryan: What Should We Test From a Hematologic Perspective in Young Cryptogenic Stroke?
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease